Clinical and genomic features of non-small cell lung cancer occurring in families

被引:1
|
作者
Miyabe, Shingo [1 ,2 ]
Ito, Shin [3 ]
Sato, Ikuro [4 ]
Abe, Jiro [1 ,5 ]
Tamai, Keiichi [3 ,5 ]
Mochizuki, Mai [3 ,5 ]
Fujimori, Haruna [5 ]
Yamaguchi, Kazunori
Shindo, Norihisa
Shima, Hiroshi [6 ]
Yamazaki, Tomoko [3 ]
Abue, Makoto [5 ]
Okada, Yoshinori [2 ]
Yasuda, Jun [3 ,7 ,8 ]
机构
[1] Miyagi Canc Ctr Hosp, Div Thorac Surg, Natori, Japan
[2] Tohoku Univ, Inst Dev Aging & Canc, Dept Thorac Surg, Sendai, Japan
[3] Miyagi Canc Ctr Res Inst, Div Mol & Cellular Oncol, Natori, Japan
[4] Miyagi Canc Ctr Hosp, Div Pathol, Natori, Japan
[5] Miyagi Canc Ctr Res Inst, Div Canc Stem Cell, Natori, Japan
[6] Miyagi Canc Ctr Res Inst, Div Canc Chemotherapy, Natori, Japan
[7] Miyagi Canc Ctr Res Inst, Div Mol & Cellular Oncol, 47-1 Nodayama, Natori, Miyagi 9811293, Japan
[8] Saitama Med Univ, Dept Head & Neck Oncol, Int Med Ctr, Saitama, Japan
关键词
DHODH; exome; mutational signature; non-small cell lung cancer; tumor suppressor gene; GENETIC-VARIANTS; RISK; SUSCEPTIBILITY;
D O I
10.1111/1759-7714.14825
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Exposure to environmental carcinogens, such as through smoking, is a major factor in the carcinogenesis of non-small cell lung cancer (NSCLC). However, genetic factors may also contribute.Methods To identify candidate tumor suppressor genes for NSCLC, we included 23 patients (10 related pairs and 3 individuals) with NSCLC who had other NSCLC-affected first-degree relatives in a local hospital. Exome analyses for both germline and somatic (NSCLC specimens) DNA were performed for 17 cases. Germline exome data of these 17 cases revealed that most of the short variants were identical to the variants in 14KJPN (a Japanese reference genome panel of more than 14 000 individuals) and only a nonsynonymous variant in the DHODH gene, p.A347T, was shared between a pair of NSCLC patients in the same family. This variant is a known pathogenic variant of the gene for Miller syndrome.Results Somatic genetic alterations in the exome data of our samples showed frequent mutations in the EGFR and TP53 genes. Principal component analysis of the patterns of 96 types of single nucleotide variants (SNVs) suggested the existence of unique mechanisms inducing somatic SNVs in each family. Delineation of mutational signatures of the somatic SNVs with deconstructSigs for the pair of germline pathogenic DHODH variant-positive cases showed that the mutational signatures of these cases included SBS3 (homologous recombination repair defect), SBS6, 15 (DNA mismatch repair), and SBS7 (ultraviolet exposure), suggesting that disordered pyrimidine production causes increased errors in DNA repair systems in these cases.Conclusion Our results suggest the importance of the detailed collection of data on environmental exposure along with genetic information on NSCLC patients to identify the unique combinations that cause lung tumorigenesis in a particular family.
引用
收藏
页码:940 / 952
页数:13
相关论文
共 50 条
  • [21] Promoter hypermethylation of the CFTR gene and clinical/pathological features associated with non-small cell lung cancer
    Son, Ji Woong
    Kim, Young Jin
    Cho, Hyun Min
    Lee, Soo Young
    Lee, Su Man
    Kang, Jae-Ku
    Lee, Jung Uee
    Lee, Yu Mi
    Kwon, Sun Jung
    Choi, Eugene
    Na, Moon Jun
    Park, Jae Yong
    Kim, Dong Sun
    RESPIROLOGY, 2011, 16 (08) : 1203 - 1209
  • [22] Expression patterns and clinical significance of estrogen receptor in non-small cell lung cancer
    Castellanos, Mario R.
    Fanous, Ereeny
    Thaker, Rina
    Flory, Michael J.
    Seetharamu, Nagashree
    Dhar, Meekoo
    Starr, Adam
    Strange, Theodore J.
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 241
  • [23] Expression and clinical significance of SYNE3 in non-small cell lung cancer
    Wu, Yunxi
    Chen, Dehe
    Luo, Yu
    Wang, Jun
    Gong, Haiying
    Li, Junhua
    Jiang, Li
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (09): : 4436 - 4449
  • [24] Clinical features and prognostic factors in patients with bone metastases from non-small cell lung cancer
    Wu, Xiao-Tian
    Zhou, Jian-Wei
    Pan, Long-Ci
    Ge, Ting
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (05)
  • [25] Clinical use of crizotinib for the treatment of non-small cell lung cancer
    Roberts, Patrick J.
    BIOLOGICS-TARGETS & THERAPY, 2013, 7 : 91 - 101
  • [26] Squamous Non-small Cell Lung Cancer as a Distinct Clinical Entity
    Oliver, Trudy G.
    Patel, Jesal
    Akerley, Wallace
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (02): : 220 - 226
  • [27] Wedge Resection for Clinical-nO Non-Small Cell Lung Cancer
    Tsunezuka, Hiroaki
    Kato, Daishiro
    Okada, Satoru
    Furuya, Tatsuo
    Shimada, Junichi
    Inoue, Masayoshi
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1394 - S1394
  • [28] Clinical applications of circulating biomarkers in non-small cell lung cancer
    Oh, Hyun-Ji
    Imam-Aliagan, Abdulhamid B.
    Kim, Yeo-Bin
    Kim, Hyun-Jin
    Izaguirre, Issac A.
    Sung, Chang K.
    Yim, Hyungshin
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
  • [29] Clinical challenges in neoadjuvant immunotherapy for non-small cell lung cancer
    Guo, Hanfei
    Li, Wenqian
    Qian, Lei
    Cui, Jiuwei
    CHINESE JOURNAL OF CANCER RESEARCH, 2021, 33 (02) : 203 - 215
  • [30] Methylation profiling in non-small cell lung cancer: Clinical implications
    Moran, Alberto
    Fernandez-Marcelo, Tamara
    Carro, Juan
    De Juan, Carmen
    Pascua, Irene
    Head, Jacqueline
    Gomez, Ana
    Hernando, Florentino
    Torres, Antonio-Jose
    Benito, Manuel
    Iniesta, Pilar
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (03) : 739 - 746